Back to Authors

Ohinata, Aki

A5034037126 | I1343551460

Mayo Clinic

The University of Texas MD Anderson Cancer Center

Citations 1

NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA).

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3503-3503

10.1200/jco.2016.34.15_suppl.3503